|
Central America Pharmaceutical Research & Development News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Central America Pharmaceuticals.
Latest Central America Pharmaceutical Research & Development News
- Key drivers in Argentine pharmaceutical market 7 Nov 2009 06:37 GMT
... has announced the addition of the "The Pharmaceutical Market: Argentina" report to their offering. In ... pharmaceutical manufacturers. In comparison with other Latin American markets, local pharmaceutical production is strong and ... national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health ...
- Letters: The World's Best Health Care System? 7 Nov 2009 05:58 GMT
... Inturrisi The writer is a professor of pharmacology at Weill Cornell Medical College. Nicholas D. ... homogenous. I have practiced medicine in Europe, Central America and the Middle East. I have met ... lag behind almost all other industrialized and developed countries in most measures of the health ...
- The World's Best Health Care System? (5 Letters) 7 Nov 2009 06:00 GMT
... Inturrisi The writer is a professor of pharmacology at Weill Cornell Medical College. Nicholas D. ... homogenous. I have practiced medicine in Europe, Central America and the Middle East. I have met ... lag behind almost all other industrialized and developed countries in most measures of the health ...
- WEEKAHEAD-The view from Reuters editors in the Americas 7 Nov 2009 02:50 GMT
... usually the final word for the year. HONDURAS - The de facto government has effectively ... Merck , Pfizer and GlaxoSmithKline . Pharmaceutical companies are striking mega-deals, diversifying and cutting ... industry is becoming more productive in its research labs after a long dry patch. But investors ...
- Albuquerque Journal, N.M., Isabel Sanchez column: SICK AS A DOG [Albuquerque Journal, N.M.] 7 Nov 2009 01:57 GMT
... 6--Canine influenza has been confirmed in New Mexico, but there's no need to panic. Veterinarians ... says. The hospital sent samples to a pharmaceutical company that makes a canine flu vaccine ... with their flu, and cats apparently haven't developed their own species-specific flu. However, it was ...
- Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 7 Nov 2009 00:11 GMT
... Conference, November 6-8, 2009 in Albuquerque, New Mexico. "We are pleased to offer Inscrybe Healthcare ... website at www.authentidate.com Definitive Homecare Solutions, Ltd. develops and licenses its business and patient management ... software solution, CPR+ to home infusion, specialty pharmacy, and HME providers. Founded in 1993, Definitive ...
- Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CP 7 Nov 2009 00:30 GMT
... Conference, November 6-8, 2009 in Albuquerque, New Mexico. "We are pleased to offer Inscrybe Healthcare ... website at www.authentidate.com Definitive Homecare Solutions, Ltd. develops and licenses its business and patient management ... software solution, CPR+ to home infusion, specialty pharmacy, and HME providers. Founded in 1993, Definitive ...
- Markel Corp's Tom Gayner Buys ITC Holdings Corp., Patterson Companies Inc., Pool Corp., Sells Goldman Sachs Group Inc. The Progressive Corp., Yum! Brands Inc. 7 Nov 2009 00:40 GMT
... and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles ... as of 09/30/2009. DENTSPLY International Inc. designs develops manufactures and markets products in two principal ... systems and timberlands in North and South America and it seeks acquisition opportunities in other ...
- Research and Markets: In 2008, Argentina's Pharma Annual Sales Rose By 26.8% In Local Terms, Reaching 9.6 Billion Pesos (US$3.1 Billion) 6 Nov 2009 16:49 GMT
... Research and Markets: In 2008, Argentina's Pharma Annual Sales Rose By 26.8% In Local Terms, Reaching ... national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health ...
- Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 6 Nov 2009 09:41 GMT
... Staphylococcus Aureus (MRSA) Infections Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the ... 54 employees with significant experience in anti-infective research and development, who are located in Paris, ...
- Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Stru 6 Nov 2009 09:53 GMT
... Staphylococcus Aureus (MRSA) Infections Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the ... 54 employees with significant experience in anti-infective research and development, who are located in Paris, ...
- Research and Markets: In 2008, Argentina's Pharma Annual Sales Rose By 26.8% In Local Terms, Reaching 9.6 Billion Pesos (US$3.1 Billion) (BIZ) 6 Nov 2009 16:54 GMT
... and Brazil, but similar to Venezuela. The pharmacy sector, traditionally dominated by branded products, has ... pharmaceutical manufacturers. In comparison with other Latin American markets, local pharmaceutical production is strong and ... national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health ...
- Novexel commences comparative study of NXL103 to oral linezolid 6 Nov 2009 09:31 GMT
... Staphylococcus Aureus (MRSA) Infections Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the ... approximately 20 sites in the USA and Central America. The study is expected to be completed ...
- New drug for swine flu offers hope 6 Nov 2009 09:56 GMT
... also be a life saver for its developer, BioCryst Pharmaceuticals, an unprofitable biotechnology company in Birmingham, Ala., ... in an interview Thursday. Shionogi, a Japanese drug company with licensing rights from BioCryst, ran its ...
- New Drug for H1N1 Flu Offers Hope 6 Nov 2009 02:52 GMT
... Desperate, her doctors tried a still-experimental drug called peramivir. ... also be a life saver for its developer, , an unprofitable biotechnology company in Birmingham, ... in an interview Thursday. Shionogi, a Japanese drug company with licensing rights from BioCryst, ran its ...
Powered by 
Central America Pharmaceuticals News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Pharmaceutical Industry Today
|
a digital news provider
>
Pharmaceutical Research & Development
bloomberg.com:
healthday.com:
msnbc.msn.com: